Winter courses

The Center for Health Technology Assessment organizes a winter course in January 2026. The date and location will be communicated in November 2025.

Health economic aspects of pharmaceutical R&D decisions 

For Whom?

For representatives of health care innovators, investors and payers, HTA agencies, academic researchers and clinical research and market access specialists of the pharmaceutical industry or who are involved or interested in-, or influenced by decisions in pharmaceutical research and development.

Brief description

Early phase assessment of investigational medical technologies requires special skills in health technology assessment, economic modeling, and market research. Developers should explore realistic pricing assumptions and business models of these technologies before moving ahead or investing in a development program. The course – in addition to providing insights into theory – will mainly be based on case studies. Participants will construct economic models to judge the value-based price of investigational medical technologies, and evaluate their expected net present value to support indication selection and go, no-go decisions. Participation will be face-to-face with limited seating.

Lecturers:

            Prof. Zoltán Kaló                        Assoc. Prof. Balázs Nagy

Language: English only
Timing: Courses start at 9 AM, end at 4 PM
Skill requirements: Basic knowledge of statistics and/or pharmaceutical R&D, familiarity with MS Excel.
Equipment requirements: own laptop, MS Excel

• download our application form: (available from November 2025)
• fill out the form, 
• send the completed form in a .pdf format to hta@semmelweis.hu via email.

Important: After sending your registration form by email, please wait for receiving your invoice first. Only after you received your invoice transfer the registration fee.

Thank you!